XML 230 R200.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidating Guarantor Financial Information (Details) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Condensed Financial Statements, Captions [Line Items]      
Net sales $ 6,763 $ 5,918 $ 5,082
Cost of sales (5,329) (4,738) (4,079)
Gross profit 1,434 1,180 1,003
Selling, general and administrative expenses (536) (505) (474)
Amortization of intangible assets (62) (61) (77)
Research and development expenses (96) (70) (70)
Other (charges) gains, net (48) (46) (136)
Foreign exchange gain (loss), net 0 (3) 2
Gain (loss) on disposition of businesses and assets, net (2) 8 42
Operating profit (loss) 690 503 290
Equity in net earnings (loss) of affiliates 192 168 99
Interest expense (221) (204) (207)
Refinancing expense (3) (16) 0
Interest income 3 7 8
Dividend income - cost investments 80 73 57
Other income (expense), net 14 7 4
Earnings (loss) from continuing operations before tax 755 538 251
Income tax (provision) benefit (149) (112) 243
Earnings (loss) from continuing operations 606 426 494
Earnings (loss) from operation of discontinued operations 2 (80) 6
Gain (loss) on disposition of discontinued operations 0 2 0
Income tax (provision) benefit from discontinued operations (1) 29 (2)
Earnings (loss) from discontinued operations 1 (49) 4
Net earnings (loss) 607 377 498
Net (earnings) loss attributable to noncontrolling interests 0 0 0
Net earnings (loss) attributable to Celanese Corporation 607 377 498
Current assets      
Cash and cash equivalents 682 740 1,254
Trade receivables - third party and affiliates 871 827  
Non-trade receivables, net 235 253  
Inventories, net 712 610  
Deferred income taxes 104 92  
Marketable securities, at fair value 64 78  
Assets held for sale 0 9  
Other assets 35 59  
Total current assets 2,703 2,668  
Investments in affiliates 824 838  
Property, plant and equipment, net 3,269 3,017  
Deferred income taxes 421 443  
Other assets 344 289  
Goodwill 760 774 798
Intangible assets, net 197 252  
Total assets 8,518 8,281  
Current liabilities      
Short-term borrowings and current installments of long-term debt - third party and affiliates 144 228  
Trade payables - third party and affiliates 673 673  
Other liabilities 539 596  
Deferred income taxes 17 28  
Income taxes payable 12 17  
Total current liabilities 1,385 1,542  
Long-term debt 2,873 2,990  
Deferred income taxes 92 116  
Uncertain tax positions 182 273  
Benefit obligations 1,492 1,359  
Other liabilities 1,153 1,075  
Total noncurrent liabilities 5,792 5,813  
Stockholders' equity      
Total Celanese Corporation stockholders' equity 1,341 926  
Noncontrolling interests 0 0  
Total stockholders' equity 1,341 926 586
Total liabilities and equity 8,518 8,281  
Operating activities      
Net cash provided by (used in) operating activities 638 452 596
Investing activities      
Capital expenditures on property, plant and equipment (349) (201) (176)
Acquisitions, net of cash acquired (8) (46) (9)
Proceeds from sale of businesses and assets, net 6 26 171
Deferred proceeds from Ticona Kelsterbach plant relocation 159 0 412
Capital expenditures related to Ticona Kelsterbach plant relocation (204) (312) (351)
Proceeds from sale of marketable securities 0 0 15
Other, net (45) (27) (31)
Net cash provided by (used in) investing activities (441) (560) 31
Financing activities      
Short-term borrowings (repayments), net (16) (16) (9)
Proceeds from long-term debt 411 600 0
Repayments of long-term debt (591) (897) (80)
Refinancing costs (8) (24) (3)
Proceeds and (repayments) from intercompany financing activities 0 0 0
Purchases of treasury stock, including related fees (31) (48) 0
Dividends from subsidiary 0 0 0
Dividends to parent 0 0 0
Contributions from parent to subsidiary 0 0 0
Stock option exercises 20 14 14
Series A common stock dividends (34) (28) (23)
Preferred stock dividends 0 (3) (10)
Other, net (4) 14 (1)
Net cash provided by (used in) financing activities (253) (388) (112)
Exchange rate effects on cash and cash equivalents (2) (18) 63
Net increase (decrease) in cash and cash equivalents (58) (514) 578
Cash and cash equivalents at beginning of period 740 1,254 676
Cash and cash equivalents at end of period 682 740 1,254
Parent Guarantor [Member]
     
Condensed Financial Statements, Captions [Line Items]      
Net sales 0 0 0
Cost of sales 0 0 0
Gross profit 0 0 0
Selling, general and administrative expenses 0 0 0
Amortization of intangible assets 0 0 0
Research and development expenses 0 0 0
Other (charges) gains, net 0 0 0
Foreign exchange gain (loss), net 0 0 0
Gain (loss) on disposition of businesses and assets, net 0 0 0
Operating profit (loss) 0 0 0
Equity in net earnings (loss) of affiliates 605 407 491
Interest expense 0 0 0
Refinancing expense 0 0  
Interest income 0 0 0
Dividend income - cost investments 0 0 0
Other income (expense), net 0 (27) 0
Earnings (loss) from continuing operations before tax 605 380 491
Income tax (provision) benefit 2 (3) 7
Earnings (loss) from continuing operations 607 377 498
Earnings (loss) from operation of discontinued operations 0 0 0
Gain (loss) on disposition of discontinued operations 0 0 0
Income tax (provision) benefit from discontinued operations 0 0 0
Earnings (loss) from discontinued operations 0 0 0
Net earnings (loss) 607 377 498
Net (earnings) loss attributable to noncontrolling interests 0 0 0
Net earnings (loss) attributable to Celanese Corporation 607 377 498
Current assets      
Cash and cash equivalents 0 0 5
Trade receivables - third party and affiliates 0 0  
Non-trade receivables, net 0 0  
Inventories, net 0 0  
Deferred income taxes 0 0  
Marketable securities, at fair value 0 0  
Assets held for sale 0 0  
Other assets 0 0  
Total current assets 0 0  
Investments in affiliates 1,315 903  
Property, plant and equipment, net 0 0  
Deferred income taxes 0 0  
Other assets 0 0  
Goodwill 0 0  
Intangible assets, net 0 0  
Total assets 1,315 903  
Current liabilities      
Short-term borrowings and current installments of long-term debt - third party and affiliates 0 0  
Trade payables - third party and affiliates 0 0  
Other liabilities 0 0  
Deferred income taxes 0 0  
Income taxes payable (29) (26)  
Total current liabilities (29) (26)  
Long-term debt 0 0  
Deferred income taxes 0 0  
Uncertain tax positions 3 3  
Benefit obligations 0 0  
Other liabilities 0 0  
Total noncurrent liabilities 3 3  
Stockholders' equity      
Total Celanese Corporation stockholders' equity 1,341 926  
Noncontrolling interests 0 0  
Total stockholders' equity 1,341 926  
Total liabilities and equity 1,315 903  
Operating activities      
Net cash provided by (used in) operating activities (4) (42) 0
Investing activities      
Capital expenditures on property, plant and equipment 0 0 0
Acquisitions, net of cash acquired 0 0 0
Proceeds from sale of businesses and assets, net 0 0 0
Deferred proceeds from Ticona Kelsterbach plant relocation 0 0 0
Capital expenditures related to Ticona Kelsterbach plant relocation 0 0 0
Proceeds from sale of marketable securities     0
Other, net 0 0 0
Net cash provided by (used in) investing activities 0 0 0
Financing activities      
Short-term borrowings (repayments), net 0 0 0
Proceeds from long-term debt 0 0 0
Repayments of long-term debt 0 0 0
Refinancing costs 0 0 0
Proceeds and (repayments) from intercompany financing activities 0 0 0
Purchases of treasury stock, including related fees (31) (48) 0
Dividends from subsidiary 45 86 24
Dividends to parent 0 0 0
Contributions from parent to subsidiary 0 0 0
Stock option exercises 20 14 14
Series A common stock dividends (34) (28) (23)
Preferred stock dividends 0 (3) (10)
Other, net 4 16 0
Net cash provided by (used in) financing activities 4 37 5
Exchange rate effects on cash and cash equivalents 0 0 0
Net increase (decrease) in cash and cash equivalents 0 (5) 5
Cash and cash equivalents at beginning of period 0 5 0
Cash and cash equivalents at end of period 0 0 5
Issuer [Member]
     
Condensed Financial Statements, Captions [Line Items]      
Net sales 0 0 0
Cost of sales 0 0 0
Gross profit 0 0 0
Selling, general and administrative expenses 0 0 0
Amortization of intangible assets 0 0 0
Research and development expenses 0 0 0
Other (charges) gains, net 0 0 0
Foreign exchange gain (loss), net 0 0 0
Gain (loss) on disposition of businesses and assets, net 0 0 0
Operating profit (loss) 0 0 0
Equity in net earnings (loss) of affiliates 770 551 523
Interest expense (217) (173) (169)
Refinancing expense (3) (16)  
Interest income 23 21 24
Dividend income - cost investments 0 0 0
Other income (expense), net 0 2 4
Earnings (loss) from continuing operations before tax 573 385 382
Income tax (provision) benefit 32 22 109
Earnings (loss) from continuing operations 605 407 491
Earnings (loss) from operation of discontinued operations 0 0 0
Gain (loss) on disposition of discontinued operations 0 0 0
Income tax (provision) benefit from discontinued operations 0 0 0
Earnings (loss) from discontinued operations 0 0 0
Net earnings (loss) 605 407 491
Net (earnings) loss attributable to noncontrolling interests 0 0 0
Net earnings (loss) attributable to Celanese Corporation 605 407 491
Current assets      
Cash and cash equivalents 0 0 0
Trade receivables - third party and affiliates 0 0  
Non-trade receivables, net 10 10  
Inventories, net 0 0  
Deferred income taxes 0 25  
Marketable securities, at fair value 0 0  
Assets held for sale 0 0  
Other assets 6 48  
Total current assets 16 83  
Investments in affiliates 2,978 3,721  
Property, plant and equipment, net 0 0  
Deferred income taxes 17 19  
Other assets 1,903 614  
Goodwill 0 0  
Intangible assets, net 0 0  
Total assets 4,914 4,437  
Current liabilities      
Short-term borrowings and current installments of long-term debt - third party and affiliates 1,492 1,227  
Trade payables - third party and affiliates 0 0  
Other liabilities 63 87  
Deferred income taxes 16 0  
Income taxes payable (373) (309)  
Total current liabilities 1,198 1,005  
Long-term debt 2,372 2,498  
Deferred income taxes 0 0  
Uncertain tax positions 16 17  
Benefit obligations 0 0  
Other liabilities 13 14  
Total noncurrent liabilities 2,401 2,529  
Stockholders' equity      
Total Celanese Corporation stockholders' equity 1,315 903  
Noncontrolling interests 0 0  
Total stockholders' equity 1,315 903  
Total liabilities and equity 4,914 4,437  
Operating activities      
Net cash provided by (used in) operating activities 0 0 0
Investing activities      
Capital expenditures on property, plant and equipment 0 0 0
Acquisitions, net of cash acquired 0 0 0
Proceeds from sale of businesses and assets, net 0 0 0
Deferred proceeds from Ticona Kelsterbach plant relocation 0 0 0
Capital expenditures related to Ticona Kelsterbach plant relocation 0 0 0
Proceeds from sale of marketable securities     0
Other, net 0 0 0
Net cash provided by (used in) investing activities 0 0 0
Financing activities      
Short-term borrowings (repayments), net 0 0 0
Proceeds from long-term debt 400 600 0
Repayments of long-term debt (532) (827) (28)
Refinancing costs (8) (24) (3)
Proceeds and (repayments) from intercompany financing activities 140 251 31
Purchases of treasury stock, including related fees 0 0 0
Dividends from subsidiary 145 86 24
Dividends to parent (45) (86) (24)
Contributions from parent to subsidiary (100) 0 0
Stock option exercises 0 0 0
Series A common stock dividends 0 0 0
Preferred stock dividends 0 0 0
Other, net 0 0 0
Net cash provided by (used in) financing activities 0 0 0
Exchange rate effects on cash and cash equivalents 0 0 0
Net increase (decrease) in cash and cash equivalents 0 0 0
Cash and cash equivalents at beginning of period 0 0 0
Cash and cash equivalents at end of period 0 0 0
Subsidiary Guarantors [Member]
     
Condensed Financial Statements, Captions [Line Items]      
Net sales 2,572 2,277 2,046
Cost of sales (1,847) (1,704) (1,443)
Gross profit 725 573 603
Selling, general and administrative expenses (168) (183) (176)
Amortization of intangible assets (17) (14) (12)
Research and development expenses (64) (42) (41)
Other (charges) gains, net 23 68 (1)
Foreign exchange gain (loss), net 0 0 0
Gain (loss) on disposition of businesses and assets, net (1) 3 6
Operating profit (loss) 498 405 379
Equity in net earnings (loss) of affiliates 165 153 72
Interest expense (41) (38) (44)
Refinancing expense 0 0  
Interest income 48 30 27
Dividend income - cost investments 0 0 38
Other income (expense), net (39) (52) (2)
Earnings (loss) from continuing operations before tax 631 498 470
Income tax (provision) benefit (149) (91) 276
Earnings (loss) from continuing operations 482 407 746
Earnings (loss) from operation of discontinued operations 3 (78) 0
Gain (loss) on disposition of discontinued operations 0 2 0
Income tax (provision) benefit from discontinued operations (1) 28 0
Earnings (loss) from discontinued operations 2 (48) 0
Net earnings (loss) 484 359 746
Net (earnings) loss attributable to noncontrolling interests 0 0 0
Net earnings (loss) attributable to Celanese Corporation 484 359 746
Current assets      
Cash and cash equivalents 133 128 520
Trade receivables - third party and affiliates 297 246  
Non-trade receivables, net 1,651 1,400  
Inventories, net 187 164  
Deferred income taxes 87 33  
Marketable securities, at fair value 64 77  
Assets held for sale 0 9  
Other assets 18 33  
Total current assets 2,437 2,090  
Investments in affiliates 1,530 1,413  
Property, plant and equipment, net 735 650  
Deferred income taxes 382 404  
Other assets 132 125  
Goodwill 298 297  
Intangible assets, net 69 79  
Total assets 5,583 5,058  
Current liabilities      
Short-term borrowings and current installments of long-term debt - third party and affiliates 176 137  
Trade payables - third party and affiliates 258 249  
Other liabilities 353 385  
Deferred income taxes (16) 0  
Income taxes payable 384 314  
Total current liabilities 1,155 1,085  
Long-term debt 834 980  
Deferred income taxes 0 0  
Uncertain tax positions 27 28  
Benefit obligations 1,346 1,230  
Other liabilities 99 123  
Total noncurrent liabilities 2,306 2,361  
Stockholders' equity      
Total Celanese Corporation stockholders' equity 2,122 1,612  
Noncontrolling interests 0 0  
Total stockholders' equity 2,122 1,612  
Total liabilities and equity 5,583 5,058  
Operating activities      
Net cash provided by (used in) operating activities 274 49 298
Investing activities      
Capital expenditures on property, plant and equipment (145) (88) (58)
Acquisitions, net of cash acquired (8) (46) 0
Proceeds from sale of businesses and assets, net 1 4 132
Deferred proceeds from Ticona Kelsterbach plant relocation 0 0 0
Capital expenditures related to Ticona Kelsterbach plant relocation 0 0 0
Proceeds from sale of marketable securities     0
Other, net (15) (6) (4)
Net cash provided by (used in) investing activities (167) (136) 70
Financing activities      
Short-term borrowings (repayments), net (5) 3 (4)
Proceeds from long-term debt 0 0 0
Repayments of long-term debt (4) (2) (16)
Refinancing costs 0 0 0
Proceeds and (repayments) from intercompany financing activities (140) (218) (31)
Purchases of treasury stock, including related fees 0 0 0
Dividends from subsidiary 0 0 4
Dividends to parent (45) (86) (24)
Contributions from parent to subsidiary 100 0 0
Stock option exercises 0 0 0
Series A common stock dividends 0 0 0
Preferred stock dividends 0 0 0
Other, net (8) (2) (1)
Net cash provided by (used in) financing activities (102) (305) (72)
Exchange rate effects on cash and cash equivalents 0 0 0
Net increase (decrease) in cash and cash equivalents 5 (392) 296
Cash and cash equivalents at beginning of period 128 520 224
Cash and cash equivalents at end of period 133 128 520
Non-Guarantors [Member]
     
Condensed Financial Statements, Captions [Line Items]      
Net sales 5,240 4,570 3,986
Cost of sales (4,507) (3,976) (3,578)
Gross profit 733 594 408
Selling, general and administrative expenses (368) (322) (298)
Amortization of intangible assets (45) (47) (65)
Research and development expenses (32) (28) (29)
Other (charges) gains, net (71) (114) (135)
Foreign exchange gain (loss), net 0 (3) 2
Gain (loss) on disposition of businesses and assets, net 0 5 26
Operating profit (loss) 217 85 (91)
Equity in net earnings (loss) of affiliates 166 126 86
Interest expense (41) (46) (47)
Refinancing expense 0 0  
Interest income 10 9 10
Dividend income - cost investments 80 73 19
Other income (expense), net 53 84 2
Earnings (loss) from continuing operations before tax 485 331 (21)
Income tax (provision) benefit (43) (38) (149)
Earnings (loss) from continuing operations 442 293 (170)
Earnings (loss) from operation of discontinued operations (1) (2) 6
Gain (loss) on disposition of discontinued operations 0 0 0
Income tax (provision) benefit from discontinued operations 0 1 (2)
Earnings (loss) from discontinued operations (1) (1) 4
Net earnings (loss) 441 292 (166)
Net (earnings) loss attributable to noncontrolling interests 0 0 0
Net earnings (loss) attributable to Celanese Corporation 441 292 (166)
Current assets      
Cash and cash equivalents 549 612 729
Trade receivables - third party and affiliates 694 672  
Non-trade receivables, net 562 515  
Inventories, net 590 484  
Deferred income taxes 17 34  
Marketable securities, at fair value 0 1  
Assets held for sale 0 0  
Other assets 45 43  
Total current assets 2,457 2,361  
Investments in affiliates 535 530  
Property, plant and equipment, net 2,534 2,367  
Deferred income taxes 22 20  
Other assets 296 389  
Goodwill 462 477  
Intangible assets, net 128 173  
Total assets 6,434 6,317  
Current liabilities      
Short-term borrowings and current installments of long-term debt - third party and affiliates 131 190  
Trade payables - third party and affiliates 535 515  
Other liabilities 506 544  
Deferred income taxes 17 28  
Income taxes payable 35 39  
Total current liabilities 1,224 1,316  
Long-term debt 1,650 346  
Deferred income taxes 92 116  
Uncertain tax positions 136 225  
Benefit obligations 146 129  
Other liabilities 1,055 954  
Total noncurrent liabilities 3,079 1,770  
Stockholders' equity      
Total Celanese Corporation stockholders' equity 2,131 3,231  
Noncontrolling interests 0 0  
Total stockholders' equity 2,131 3,231  
Total liabilities and equity 6,434 6,317  
Operating activities      
Net cash provided by (used in) operating activities 368 445 298
Investing activities      
Capital expenditures on property, plant and equipment (204) (113) (118)
Acquisitions, net of cash acquired 0 0 (9)
Proceeds from sale of businesses and assets, net 5 22 39
Deferred proceeds from Ticona Kelsterbach plant relocation 159 0 412
Capital expenditures related to Ticona Kelsterbach plant relocation (204) (312) (351)
Proceeds from sale of marketable securities     15
Other, net (30) (21) (27)
Net cash provided by (used in) investing activities (274) (424) (39)
Financing activities      
Short-term borrowings (repayments), net (11) (19) (5)
Proceeds from long-term debt 11 0 0
Repayments of long-term debt (55) (68) (36)
Refinancing costs 0 0 0
Proceeds and (repayments) from intercompany financing activities 0 (33) 0
Purchases of treasury stock, including related fees 0 0 0
Dividends from subsidiary 0 0 0
Dividends to parent (100) 0 (4)
Contributions from parent to subsidiary 0 0 0
Stock option exercises 0 0 0
Series A common stock dividends 0 0 0
Preferred stock dividends 0 0 0
Other, net 0 0 0
Net cash provided by (used in) financing activities (155) (120) (45)
Exchange rate effects on cash and cash equivalents (2) (18) 63
Net increase (decrease) in cash and cash equivalents (63) (117) 277
Cash and cash equivalents at beginning of period 612 729 452
Cash and cash equivalents at end of period 549 612 729
Consolidation Eliminations [Member]
     
Condensed Financial Statements, Captions [Line Items]      
Net sales (1,049) (929) (950)
Cost of sales 1,025 942 942
Gross profit (24) 13 (8)
Selling, general and administrative expenses 0 0 0
Amortization of intangible assets 0 0 0
Research and development expenses 0 0 0
Other (charges) gains, net 0 0 0
Foreign exchange gain (loss), net 0 0 0
Gain (loss) on disposition of businesses and assets, net (1) 0 10
Operating profit (loss) (25) 13 2
Equity in net earnings (loss) of affiliates (1,514) (1,069) (1,073)
Interest expense 78 53 53
Refinancing expense 0 0  
Interest income (78) (53) (53)
Dividend income - cost investments 0 0 0
Other income (expense), net 0 0 0
Earnings (loss) from continuing operations before tax (1,539) (1,056) (1,071)
Income tax (provision) benefit 9 (2) 0
Earnings (loss) from continuing operations (1,530) (1,058) (1,071)
Earnings (loss) from operation of discontinued operations 0 0 0
Gain (loss) on disposition of discontinued operations 0 0 0
Income tax (provision) benefit from discontinued operations 0 0 0
Earnings (loss) from discontinued operations 0 0 0
Net earnings (loss) (1,530) (1,058) (1,071)
Net (earnings) loss attributable to noncontrolling interests 0 0 0
Net earnings (loss) attributable to Celanese Corporation (1,530) (1,058) (1,071)
Current assets      
Cash and cash equivalents 0 0 0
Trade receivables - third party and affiliates (120) (91)  
Non-trade receivables, net (1,988) (1,672)  
Inventories, net (65) (38)  
Deferred income taxes 0 0  
Marketable securities, at fair value 0 0  
Assets held for sale 0 0  
Other assets (34) (65)  
Total current assets (2,207) (1,866)  
Investments in affiliates (5,534) (5,729)  
Property, plant and equipment, net 0 0  
Deferred income taxes 0 0  
Other assets (1,987) (839)  
Goodwill 0 0  
Intangible assets, net 0 0  
Total assets (9,728) (8,434)  
Current liabilities      
Short-term borrowings and current installments of long-term debt - third party and affiliates (1,655) (1,326)  
Trade payables - third party and affiliates (120) (91)  
Other liabilities (383) (420)  
Deferred income taxes 0 0  
Income taxes payable (5) (1)  
Total current liabilities (2,163) (1,838)  
Long-term debt (1,983) (834)  
Deferred income taxes 0 0  
Uncertain tax positions 0 0  
Benefit obligations 0 0  
Other liabilities (14) (16)  
Total noncurrent liabilities (1,997) (850)  
Stockholders' equity      
Total Celanese Corporation stockholders' equity (5,568) (5,746)  
Noncontrolling interests 0 0  
Total stockholders' equity (5,568) (5,746)  
Total liabilities and equity (9,728) (8,434)  
Operating activities      
Net cash provided by (used in) operating activities 0 0 0
Investing activities      
Capital expenditures on property, plant and equipment 0 0 0
Acquisitions, net of cash acquired 0 0 0
Proceeds from sale of businesses and assets, net 0 0 0
Deferred proceeds from Ticona Kelsterbach plant relocation 0 0 0
Capital expenditures related to Ticona Kelsterbach plant relocation 0 0 0
Proceeds from sale of marketable securities     0
Other, net 0 0 0
Net cash provided by (used in) investing activities 0 0 0
Financing activities      
Short-term borrowings (repayments), net 0 0 0
Proceeds from long-term debt 0 0 0
Repayments of long-term debt 0 0 0
Refinancing costs 0 0 0
Proceeds and (repayments) from intercompany financing activities 0 0 0
Purchases of treasury stock, including related fees 0 0 0
Dividends from subsidiary (190) (172) (52)
Dividends to parent 190 172 52
Contributions from parent to subsidiary 0 0 0
Stock option exercises 0 0 0
Series A common stock dividends 0 0 0
Preferred stock dividends 0 0 0
Other, net 0 0 0
Net cash provided by (used in) financing activities 0 0 0
Exchange rate effects on cash and cash equivalents 0 0 0
Net increase (decrease) in cash and cash equivalents 0 0 0
Cash and cash equivalents at beginning of period 0 0 0
Cash and cash equivalents at end of period $ 0 $ 0 $ 0